Revere, MA, United States of America

Juan Pablo Maianti

This inventor holds 12 USPTO granted patents and 7 published patent applications. Top assignee: Harvard College. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Pablo Maianti. Retrieved from https://idiyas.com/inventor/juan-pablo-maianti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 223(Granted Patents)


Location History:

  • Cambridge, MA (US) (2016 - 2024)
  • Revere, MA (US) (2020 - 2024)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Juan Pablo Maianti - Innovative Inventor from Revere, MA

Introduction: Juan Pablo Maianti is a talented inventor based in Revere, Massachusetts, known for his groundbreaking contributions to various industries.

Latest Patents: Juan Pablo Maianti holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Juan Pablo Maianti has successfully developed cutting-edge solutions that have revolutionized the way we approach everyday challenges.

Collaborations: Throughout his career, Juan Pablo Maianti has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Juan Pablo Maianti's innovative spirit and dedication to creating impactful inventions make him a standout figure in the world of technology and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…